Zynerba Pharmaceuticals Inc (ZYNE.OQ)
ZYNE.OQ on NASDAQ Stock Exchange Global Market
8.09USD
18 Apr 2019
8.09USD
18 Apr 2019
Change (% chg)
$-0.14 (-1.70%)
$-0.14 (-1.70%)
Prev Close
$8.23
$8.23
Open
$8.12
$8.12
Day's High
$8.19
$8.19
Day's Low
$7.60
$7.60
Volume
197,334
197,334
Avg. Vol
239,632
239,632
52-wk High
$12.50
$12.50
52-wk Low
$2.76
$2.76
About
Zynerba Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in developing and commercializing transdermal synthetic cannabinoid treatments for patients with high unmet needs. Its development pipeline includes two product candidates: ZYN002 and ZYN001. ZYN002 is a synthetic cannabidiol (CBD), which... (more)
Overall
| Beta: | -- |
| Market Cap(Mil.): | $128.07 |
| Shares Outstanding(Mil.): | 13.26 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| ZYNE.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 69.30 | 32.55 |
| EPS (TTM): | -2.62 | -- | -- |
| ROI: | -55.80 | 8.91 | 13.83 |
| ROE: | -55.80 | 10.06 | 15.25 |
Estimates